Manavjeet Sidhu

Manavjeet Sidhu practices at Kaiser Permanente Fresno Medical Center in Fresno, California, part of Kaiser Permanente.

Manavjeet Sidhu's NPI, 1861849101, was assigned on May 17, 2016. Manavjeet Sidhu graduated from New York University School of Medicine in 2015. Manavjeet Sidhu holds California license A150589.

Manavjeet Sidhu's primary practice is Kaiser Permanente Fresno Medical Center, at 7300 North Fresno St, Fresno, CA 93720 in Fresno County. The practice phone is (559) 448-4500.

Manavjeet Sidhu's primary practice is Kaiser Permanente Fresno Medical Center in Fresno, California, part of Kaiser Permanente. Manavjeet Sidhu is also affiliated with Community Regional Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Manavjeet Sidhu to 6 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Manavjeet Sidhu practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Manavjeet Sidhu's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Manavjeet Sidhu is board certified in emergency medicine by the American Board of Emergency Medicine. Manavjeet Sidhu is licensed in California.

CMS data shows 113 Medicare services from Manavjeet Sidhu across 2 procedure codes in 2024, for 113 Medicare patients. Medicare paid $11,706 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Manavjeet Sidhu in 2024. The largest group is under 65, with 45 patients. 69% of them have high blood pressure, and 60% have high cholesterol. 72% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Manavjeet Sidhu's median patient age at 38, with 58% women.

In 2024, Manavjeet Sidhu wrote 202 Medicare Part D claims for 152 patients. 91% of them were for generic drugs. CMS names the drug for 88 of them, across 4 drugs with 11 or more claims each, at $2,175 in total drug cost. In 2023, CMS named 84 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Manavjeet Sidhu for performance year 2024, reported as part of a group. Manavjeet Sidhu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Manavjeet Sidhu graduated from New York University School of Medicine in 2015.

Manavjeet Sidhu is in network with 2 carriers, including Regence Health Plans and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.